FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · point in time

ULTRAGENYX PHARMACEUTICAL INC.: cash_and_equivalents

One fact, its scope and the complete path back to the official record.

Period: as of 2021-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/72d18fd7-46e5-4d68-aa6b-e2007a6e6c71

Reported value

$307.584M{"amount": 307584000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Entity
ULTRAGENYX PHARMACEUTICAL INC.
Metric
cash_and_equivalents
Period
as of 2021-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0000950170-22-001284 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T15:13:48.701378+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001515673/cash-and-equivalents/2021-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.